Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Choline alphoscerate and nimodipine in subcortical vascular cognitive impairment
NCT03228498Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Start
- May 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of choline alfoscerate in subcortical vascular cognitive impairment (SVCI), sponsored by Azienda Ospedaliero-Universitaria Careggi. Started May 2017; status: completed.
02
Drugs
choline alfoscerate
03
Conditions
subcortical vascular cognitive impairment (SVCI)
Beyond the preview
Go deeper on NCT03228498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03228498.